Zomdf is in a good spot to catch a bounce to .47. Then .82 ,gap at .99. Once this is over $1.00 it will squeeze to 2.08 which is my profit target.
If you use MA's. This broke the reclaimed and just held the retest of the 200 day SMA.
This capitulated in March with over 282 million is sale vol. Since then you have a rounded bottom. And recently the tech company that uses AI for you furry friends had great earnings.
I believe that this is a $2 stock by mid next year. But DYOR.
If you use MA's. This broke the reclaimed and just held the retest of the 200 day SMA.
This capitulated in March with over 282 million is sale vol. Since then you have a rounded bottom. And recently the tech company that uses AI for you furry friends had great earnings.
I believe that this is a $2 stock by mid next year. But DYOR.
Trade active
Stop .59Note
Russell Kevin Klass, Senior Vice President of Sales at Zomedica Corp., purchased 253,007 shares of common stock on November 6, 2025. Just a small update. There could be a million reasons to sell a stock but only one reason to buy. Not Financial advise. 
I AM HIM
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
I AM HIM
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.